Turkish Validity and Reliability of SGRQ-I
1 other identifier
observational
180
1 country
1
Brief Summary
The Saint George Respiratory Questionnaire (SGRQ) questionnaire is a frequently used questionnaire in the respiratory patient group, and the Turkish version of this questionnaire, which was created for use in idiopathic pulmonary fibrosis patients, is not available. There is no commonly used quality of life questionnaire in patients with idiopathic pulmonary fibrosis. The aim of the study is to translate and validate the SGRQ idiopathic pulmonary fibrosis version of questionnaire into Turkish.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 17, 2021
CompletedFirst Posted
Study publicly available on registry
December 7, 2021
CompletedStudy Start
First participant enrolled
January 9, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2026
CompletedMay 1, 2025
April 1, 2025
4 years
November 17, 2021
April 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Saint George Respiratory Questionnaire - Idiopathic Pulmonary Fibrosis Version (SGRQ-I)
SGRQ-I consists of 34 self-complementing items. It was developed as an IPF-specific version of SGRQ. Different scales are used to score the SGRQ-I, resulting in an overall score and three domain scores: Effects, Activities, and Symptoms. Scores range from 0 to 100, with higher scores indicating more impaired health related quality of life.
Change from baseline at 1 week.
Secondary Outcomes (1)
Saint George's Respiratory Questionnaire (SGRQ)
Change from baseline at 1 week.
Interventions
Cases diagnosed with Idiopathic pulmonary fibrosis (IPF) in the chest diseases outpatient clinic will be informed about the study, and the informed consent form will be signed by the specialist physician and demographic information will be obtained from the cases who accepted to be included in the study. The surveys will be contacted by the patient at 1-week intervals and answered by the patient by the responsible researcher and chest diseases physician.
Eligibility Criteria
Diagnosed with Idiopathic Pulmonary Fibrosis
You may qualify if:
- Be over 18 years old
- Having a Diagnosis of Idiopathic Pulmonary Fibrosis
- To be literate in Turkish
You may not qualify if:
- Exacerbation or exacerbation in the last 6 weeks
- Presence of comorbidities affecting ambulation
- Cognitive impairment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Esra Pehlivan
Istanbul, Üsküdar, 34668, Turkey (Türkiye)
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
November 17, 2021
First Posted
December 7, 2021
Study Start
January 9, 2022
Primary Completion
January 1, 2026
Study Completion
January 1, 2026
Last Updated
May 1, 2025
Record last verified: 2025-04